FIRM FIXED PRICE

HIKMA PHARMACEUTICALS USA INC. - 4569789912!ETOMIDATE 40 MG/20 ML VIAL 20ML

PIID: SPE2D326F0710
Signed Date: Oct 21, 2025Effective Date: Oct 21, 2025End Date: Closed on Oct 22, 2025
Award $
$431.2
Vendor
HIKMA PHARMACEUTICALS USA INC.
NAICS
325411
Signed Date
Oct 21, 2025

Key Details

Dollars Obligated
$431.2
Base & All Options
$431.2
Awarding Agency
Department of Defense
Awarding Sub-Agency
Defense Logistics Agency
Product Service Code
6505 - DRUGS AND BIOLOGICALS
Extent Competed
FULL AND OPEN COMPETITION
Place of Performance
BERKELEY HEIGHTS, NJ, 079222819, CD-NJ-07

Description

4569789912!ETOMIDATE 40 MG/20 ML VIAL 20ML

Context & Analysis

On Oct 21, 2025, Department of Defense obligated $431.2 to HIKMA PHARMACEUTICALS USA INC. for 4569789912!etomidate 40 mg/20 ml vial 20ml. The award is classified under NAICS 325411 — MEDICINAL AND BOTANICAL MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition. Performance is located in BERKELEY HEIGHTS, NJ.

Contractor Information

UEI: NQJ5E87TKNB1
CAGE Code: 32655
Location: EATONTOWN, NJ
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related